Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Postoperative Arthrofibrosis Prevention in ACL Reconstruction
NCT07135687Phase 4Not yet recruiting
- Sponsor
- Rush University Medical Center
- Start
- Aug 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Arthrofibrosis comparing Losartan with Placebo (2 arms). Primary endpoint: Range of Motion at 12 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
losartan
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT07135687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07135687.